Compare ELUT & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELUT | MLSS |
|---|---|---|
| Founded | 2015 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.6M | 42.6M |
| IPO Year | 2020 | 1996 |
| Metric | ELUT | MLSS |
|---|---|---|
| Price | $0.85 | $0.31 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $1.25 |
| AVG Volume (30 Days) | ★ 104.0K | 93.3K |
| Earning Date | 11-05-2026 | 08-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,293,000.00 | $8,973,982.00 |
| Revenue This Year | N/A | $11.14 |
| Revenue Next Year | N/A | $13.80 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.99 |
| 52 Week Low | $0.50 | $0.22 |
| 52 Week High | $1.39 | $0.58 |
| Indicator | ELUT | MLSS |
|---|---|---|
| Relative Strength Index (RSI) | 53.05 | 31.54 |
| Support Level | $0.75 | $0.30 |
| Resistance Level | $0.87 | $0.31 |
| Average True Range (ATR) | 0.07 | 0.03 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 74.91 | 27.24 |
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.